-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IKWzDLb4Ilmogj5JkzDW0Fkc0hQP5aC9zG4FrR52qvvztkpSANp8aPR0xGcNpGbd 2r0eM04LP8Gk8QIIMXyNnw== 0000014272-05-000075.txt : 20050303 0000014272-05-000075.hdr.sgml : 20050303 20050303173400 ACCESSION NUMBER: 0000014272-05-000075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050301 FILED AS OF DATE: 20050303 DATE AS OF CHANGE: 20050303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIGAL ELLIOT CENTRAL INDEX KEY: 0001202294 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 05658956 BUSINESS ADDRESS: STREET 1: BRISTOL-MYERS SQUIBB CO. STREET 2: 345 PARK AVE. CITY: NEW YORK STATE: NY ZIP: 10154 4 1 sig370.xml X0202 4 2005-03-01 0 0000014272 BRISTOL MYERS SQUIBB CO (BMY) 0001202294 SIGAL ELLIOT BRISTOL-MYERS SQUIBB COMPANY RT. 206 & PROVINCELINE ROAD PRINCETON NJ 08540 0 1 0 0 SVP, Global Clin & Pharm Dev Common Stock, $0.10 par value 2005-03-01 4 F 0 3038 0 D 101897.00 D Common Stock, $0.10 par value 2005-03-01 4 A 0 17250 0 A 119147.00 D Common Stock, $0.10 par value 1637.53 I By BMY Savings & Investment Program Executive Option (right to buy) 25.45 2005-03-01 4 A 0 103500 0 A 2015-02-28 Common Stock, $0.10 par value 103500.00 103500.00 D Shares withheld for payment of taxes upon vesting of restricted stock. Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Based on a plan statement as of the end of the most recent fiscal quarter. Option is not exercisable until the earlier of (i) the closing share price of common stock achieving a price of at least 15% above the option grant price and remaining at that price for seven consecutive trading days or (ii) the ninth anniversary of the grant date. Shares underlying option vest 25% a year, on a cumulative basis, commencing one year after the date of grant. By: /s/ Sonia Vora, Attorney-in-Fact 2005-03-03 -----END PRIVACY-ENHANCED MESSAGE-----